Musa Yılmaz
- Hematology top 0.5%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 2%
- Genetics top 2%
- Oncology top 5%
- Co-authors
- Hagop M. KantarjianFarhad RavandiElias JabbourNicholas J. ShortTapan M. KadiaNaval DaverGautam BorthakurMarina Konopleva
- Topics
- Acute Myeloid Leukemia Research (88 papers)Chronic Myeloid Leukemia Treatments (65 papers)Chronic Lymphocytic Leukemia Research (48 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesTürkiyeGeorgia
In The Last Decade
Musa Yılmaz
131 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 86
- Hematology 1.5k
- Molecular Biology 689
- Public Health, Environmental and Occupational Health 641
- Genetics 596
- Oncology 553
Countries citing papers authored by Musa Yılmaz
This map shows the geographic impact of Musa Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Musa Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Musa Yılmaz more than expected).
Fields of papers citing papers by Musa Yılmaz
This network shows the impact of papers produced by Musa Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Musa Yılmaz. The network helps show where Musa Yılmaz may publish in the future.
Co-authorship network of co-authors of Musa Yılmaz
This figure shows the co-authorship network connecting the top 25 collaborators of Musa Yılmaz. A scholar is included among the top collaborators of Musa Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Musa Yılmaz. Musa Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 15 | |
| 10 | 13 | |
| 11 | 36 | |
| 12 | 6 | |
| 13 | 37 | |
| 14 | Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia | 11 |
| 15 | 17 | |
| 16 | 16 | |
| 17 | 5 | |
| 18 | 66 | |
| 19 | 36 | |
| 20 | 37 |
About Musa Yılmaz
Musa Yılmaz is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 149 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (88 papers), Chronic Myeloid Leukemia Treatments (65 papers) and Chronic Lymphocytic Leukemia Research (48 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (596 citations) and Public Health, Environmental and Occupational Health (641 citations). Musa Yılmaz has collaborated with scholars based in United States, Türkiye and Georgia. Frequent co-authors include Hagop M. Kantarjian, Farhad Ravandi, Elias Jabbour, Nicholas J. Short, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Marina Konopleva, Courtney D. DiNardo and Guillermo Garcia‐Manero. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.